Amplify Alternative Harvest ETF (MJ)
| Assets | $250.68M |
| Expense Ratio | 0.75% |
| PE Ratio | 16.86 |
| Shares Out | 4.22M |
| Dividend (ttm) | $0.59 |
| Dividend Yield | 2.17% |
| Ex-Dividend Date | Dec 30, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 36.83% |
| Volume | 25,832 |
| Open | 27.00 |
| Previous Close | 27.07 |
| Day's Range | 26.75 - 27.00 |
| 52-Week Low | 21.05 |
| 52-Week High | 46.75 |
| Beta | 1.18 |
| Holdings | 9 |
| Inception Date | Dec 2, 2015 |
About MJ
Fund Home PageThe Amplify Alternative Harvest ETF (MJ) is an exchange-traded fund that is based on the Prime Alternative Harvest index. The fund tracks an index of global firms engaged in the legal cultivation, production, marketing or distribution of cannabis, cannabinoids or tobacco products. The portfolio is weighted by market cap or equally based on a proprietary system. MJ was launched on Dec 2, 2015 and is issued by Amplify Investments.
Top Holdings
| Name | Symbol | Weight |
|---|---|---|
| Amplify Seymour Cannabis ETF | CNBS | 51.23% |
| Cronos Group Inc. | CRON | 9.81% |
| Tilray Brands, Inc. | TLRY | 9.75% |
| Canopy Growth Corporation | WEED | 7.08% |
| Village Farms International, Inc. | VFF | 6.05% |
| SNDL Inc. | SNDL | 5.92% |
| Aurora Cannabis Inc. | ACB | 4.53% |
| High Tide Inc. | HITI | 3.73% |
| Organigram Global Inc. | OGI | 1.92% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.59122 | Dec 31, 2025 |
| Dec 30, 2024 | $0.29001 | Dec 31, 2024 |
| Sep 27, 2024 | $0.71437 | Sep 30, 2024 |
| Jun 27, 2024 | $2.036 | Jun 28, 2024 |
| Mar 26, 2024 | $0.66903 | Mar 28, 2024 |
| Dec 27, 2023 | $0.6696 | Dec 29, 2023 |
Performance
MJ had a total return of -17.22% in the past year, including dividends. Since the fund's inception, the average annual return has been -16.31%.
News
Marijuana Stocks to Watch Before the Next Cannabis Rally
The cannabis sector continues to attract investors seeking long-term growth opportunities in 2026. Although volatility remains high, many marijuana companies are improving operations and cutting costs...
3 Top Picks For Marijuana Stocks Investors To See Profits In 2026
For marijuana stock investors, the way the industry as a whole progresses determines a great deal for them. For example, no one wants to invest in a struggling industry even if it's been trendy along ...
Focus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Companies developing cannabis-based medicines say U.S. moves to loosen restrictions on the drug could unlock private funding and the public markets, providing a lifeline to the struggling cannabis in...
Top U.S. Marijuana Stocks to Watch in April 2026 as the Sector Heats Up
The U.S. cannabis sector continues showing strong long-term growth potential in 2026. The legal market continues to expand across multiple states. In fact, the industry is projected to grow significan...
Cannabis Stocks Soared—Than Sank. Here's What Investors Need to Know.
Marijuana-related investments were flying high this morning. Then they reversed course, and quickly.
Trump signs executive order to reschedule cannabis. Here's what's next
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted t...
Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC
Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the in...
Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification
Cannabis stocks rallied on a Wall Street Journal report that President Donald Trump is contemplating reclassifying weed as having a lower danger level. Such a move would be "a gamechanger" for the ind...
Amplify ETFs Aligns Global and U.S. Cannabis Exposure Across MJ and CNBS
CHICAGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Amplify ETFs announces the realignment of its cannabis ETFs to provide investors with dynamic exposure to the cannabis industry. On January 28, 2025, the Amp...
Cannabis stocks rally after Trump supports moving drug to less restrictive category
GOP presidential nominee Donald Trump supports Schedule III classification for cannabis, which has already been proposed by the Biden administration.
Amplify ETFs Declares June Income Distributions for its ETFs
CHICAGO, June 27, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces June income distributions for its ETFs. ETF Name Ticker Amount per Share Ex-Date Record Date Payable Date Amplify AI Powered Equity ...
DEA to Reclassify Marijuana | Daily Stock Market Wrap 4/30
The stock market sank in the final stretch of April and bond yields climbed on concern that stubborn inflation will force the Federal Reserve to keep interest rates higher for longer. On the eve of th...
Biden administration to ease federal restrictions on marijuana
CNBC's Brandon Gomez joins 'Power Lunch' to discuss the Biden administration's plan to reclassify marijuana, easing federal restrictions.
Cannabis stocks rally as AP reports imminent rescheduling proposal by DEA
Cannabis stocks were up sharply on Tuesday on a report by the Associated Press that the U.S. Drug Enforcement Administration is poised to propose the lowering of cannabis to a Schedule III controlled ...
Amplify ETFs Completes Acquisition to Reach $9.1 Billion AUM Across 31 ETFs
CHICAGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announced today it has completed its previously announced acquisition of ETF Managers Group (ETFMG) exchange-traded fund (ETF) assets, which con...
2024's Cannabis Investment Landscape: Top Marijuana ETFs to Consider
The cannabis industry is rapidly evolving, attracting attention from investors seeking long-term growth. As legalization spreads globally, marijuana stocks and ETFs (Exchange-Traded Funds) are becomin...
A key Marijuana financing bill moves forward in the U.S. Senate
Cannabis stocks are in focus after the Secure and Fair Enforcement Regulation Banking Act moved forward in the upper chamber of Congress on Wednesday. What the renegotiated SAFER means for cannabis co...
Cannabis stock rise as Senate committee OKs cannabis banking bill
Cannabis stocks moved up Wednesday after the U.S. Senate Committee on Banking, Housing and Urban Affairs approved the Secure and Fair Enforcement Regulation Banking Act, now known as the SAFER Banking...
Cannabis banking bill looks poised to get Senate committee's OK on Sept. 27
The Senate Banking Committee looks set to vote in a week and a half to advance a much-anticipated bill that aims to make it easier for the financial industry to work with cannabis companies.
Marijuana Watchlist: September 2023's Standout ETFs in Cannabis
In 2023, the cannabis industry and top marijuana stocks are blazing a trail of exponential growth, presenting investors with a unique opportunity to tap into this flourishing sector. As regulatory lan...
Cannabis ETFs boom as HHS recommendation to ease restrictions raises hopes for federal reform
Marijuana-related ETF's are trading higher in September after HHS recommended that the U.S. reclassify and ease restrictions on marijuana.
Cannabis stocks gain as banking bill finds traction in Senate, but House OK looks challenging
Cannabis stocks advanced Thursday, helped by news that a key Senate committee could soon vote to advance a widely followed bill that aims to make it easier for the financial industry to work with cann...
Possible cannabis reclassification fuels fund optimism
Possible cannabis reclassification fuels fund optimism.
HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain
The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many q...
U.S. Dept. of Health and Human Services recommends re-scheduling cannabis, as stocks in the sector rally
The U.S. Department of Health and Human Services is recommending to the U.S. Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under U.S. law ...